Dr. Kruczek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
71 W 156th St
Ste 401
Harvey, IL 60426Phone+1 708-339-4800Fax+1 708-339-4814
Education & Training
Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 2010 - 2013
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2010
Certifications & Licensure
IL State License 2012 - 2026
IN State License 2023 - 2023
Clinical Trials
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors Start of enrollment: 2018 Jun 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 50 citationsSole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiableDaniel J. Landsburg, Marissa K. Falkiewicz, Adam M. Petrich, Benjamin A. Chu, Amir Behdad
British Journal of Haematology. 2016-11-01 - 35 citationsThe impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment erasChadi Nabhan, Briseis Aschebrook-Kilfoy, Brian C.-H. Chiu, Kimberly R. Kruczek, Sonali M. Smith
American Journal of Hematology. 2014-06-01 - 38 citationsExtramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012.Megan Ratterman, Kimberly Kruczek, Suela Sulo, Tait D. Shanafelt, Neil E. Kay
Leukemia Research. 2014-03-01
Press Mentions
Phase 2 Study of Duvelisib in Previously Treated Patients with Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (BRIO)December 12th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
